Papanicolaou testing among women in the southern United States
- PMID: 18582173
- PMCID: PMC2942751
- DOI: 10.1089/jwh.2007.0576
Papanicolaou testing among women in the southern United States
Abstract
Background: Cervical cancer is largely preventable with screening using Papanicolaou (Pap) testing. We examined Pap testing among southern women, mostly of low income and educational status, to determine if rates were similar to those reported nationally and to examine which factors were related to receipt of Pap tests.
Methods: Baseline interview data from 19,046 women aged 40-79 enrolled at community health centers into the Southern Community Cohort were analyzed. The percentages of women reporting a recent Pap test (within the past 3 years) were compared according to sociodemographic, healthcare access, and health-related behavior variables. Logistic regression analyses were employed to compute odds ratios (ORs) and corresponding 95% confidence intervals (95% CI).
Results: Overall, 88% of the women reported having received a recent Pap test. Screening rates were high among all racial/ethnic groups, but highest for African American women. Not having a Pap test was significantly associated with lower education (OR declining to 0.73, 95% CI 0.64-0.85, among those with less than a high school education), lower income (OR declining to 0.61, 95% CI 0.43-0.87, among those with annual household incomes <$15,000), and not having health insurance (OR 0.83, 95% CI 0.71-0.97). The most common reason reported by women as to why they had not a Pap test was cost (25%), followed by reporting a doctor had not recommended the test (22%).
Conclusions: Pap testing was most frequent among African American women. Subsets, such as women with less education, low income, and no health insurance, however, may not be adequately screened for cervical cancer.
Similar articles
-
Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.Prev Med. 2004 Aug;39(2):270-8. doi: 10.1016/j.ypmed.2004.03.035. Prev Med. 2004. PMID: 15226035
-
Differences in cervical cancer screening and follow-up for black and white women in the United States.Gynecol Oncol. 2021 Feb;160(2):369-374. doi: 10.1016/j.ygyno.2020.11.027. Epub 2020 Dec 13. Gynecol Oncol. 2021. PMID: 33323276
-
Utilization of papanicolaou smears by South Asian women living in the United States.J Gen Intern Med. 2003 May;18(5):377-84. doi: 10.1046/j.1525-1497.2003.20427.x. J Gen Intern Med. 2003. PMID: 12795737 Free PMC article.
-
The association of obesity and cervical cancer screening: a systematic review and meta-analysis.Obesity (Silver Spring). 2009 Feb;17(2):375-81. doi: 10.1038/oby.2008.480. Epub 2008 Nov 6. Obesity (Silver Spring). 2009. PMID: 18997682 Free PMC article. Review.
-
Cervical cancer: disparities in screening, treatment, and survival.Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):242s-247s. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646519 Review. No abstract available.
Cited by
-
Lower Compliance with Cervical Cancer Screening Guidelines Among Vegetarians in North America.J Prev (2022). 2022 Dec;43(6):783-800. doi: 10.1007/s10935-022-00691-2. Epub 2022 Jun 27. J Prev (2022). 2022. PMID: 35759069
-
Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.J Womens Health (Larchmt). 2019 Aug;28(8):1094-1104. doi: 10.1089/jwh.2018.7141. Epub 2019 Mar 15. J Womens Health (Larchmt). 2019. PMID: 30874477 Free PMC article.
-
Effect of structured training programme on the knowledge and behaviors of breast and cervical cancer screening among the female teachers in Turkey.BMC Womens Health. 2017 Dec 7;17(1):123. doi: 10.1186/s12905-017-0478-8. BMC Womens Health. 2017. PMID: 29216918 Free PMC article.
-
Number of Primary Care Visits Associated with Screening for Cervical Dysplasia among Women with HIV Infection in Harris County, Texas, United States of America.HIV Adv Res Dev. 2015;1(2):107. Epub 2015 Feb 16. HIV Adv Res Dev. 2015. PMID: 27500276 Free PMC article.
-
Cervical cancer stem cells.Cell Prolif. 2015 Dec;48(6):611-25. doi: 10.1111/cpr.12216. Cell Prolif. 2015. PMID: 26597379 Free PMC article. Review.
References
-
- Jemal A. Siegel R. Ward E. Hao Y. Xu J. Murray T. Thun MJ. Cancer statistics. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Screening for cervical cancer: Recommendations and rationale. Am J Nurs. 2003;103:101. - PubMed
-
- Smith RA. Cokkinides V. Eyre HJ. Cancer screening in the United States, 2007: A review of current guidelines, practices, and prospects. CA Cancer J Clin. 2007;57:90. - PubMed
-
- ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995) Obstet Gynecol. 2003;102:417. - PubMed
-
- Behavioral Risk Factor Surveillance System Prevalence Data. National Center for Chronic Disease Prevention and Health Promotion 2006. www.cdc.gov/brfss/index.htm. www.cdc.gov/brfss/index.htm
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
